Literature DB >> 10525192

Expression of the highly conserved RNA binding protein KOC in embryogenesis.

F Mueller-Pillasch1, B Pohl, M Wilda, U Lacher, M Beil, C Wallrapp, H Hameister, W Knöchel, G Adler, T M Gress.   

Abstract

The human KOC gene which is highly expressed in cancer shows typical structural features of an RNA binding protein. We analyzed the temporal and spatial expression pattern of KOC in mouse embryos at different gestational ages. The expression of KOC seems to be ubiquitous at early stages. During advanced gestation highest KOC expression occurs in the gut, pancreas, kidney, and in the developing brain. The expression pattern of KOC was compared to its Xenopus homologue Vg1-RBP during frog development. Similar expression was found in these organs suggesting an important functional role of the homologous proteins in embryonic development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525192     DOI: 10.1016/s0925-4773(99)00160-4

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  57 in total

1.  Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability.

Authors:  Jacob Nielsen; Mette Ahm Kristensen; Martin Willemoës; Finn Cilius Nielsen; Jan Christiansen
Journal:  Nucleic Acids Res       Date:  2004-08-16       Impact factor: 16.971

2.  IMP3 is upregulated in primary ovarian mucinous carcinoma and promotes tumor progression.

Authors:  Qin Zhu; Yuqing Qu; Qiongyan Zhang; Linghui Lu; Weiwei Weng; Hao Zhang; Lihong Zhang; Yan Ning; Yiqin Wang
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions.

Authors:  B-J Wang; L Wang; S-Y Yang; Z-J Liu
Journal:  Clin Transl Oncol       Date:  2014-09-03       Impact factor: 3.405

4.  IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes.

Authors:  Alessandro Del Gobbo; Annamaria Morotti; Anna Eleonora Colombo; Valentina Vaira; Giulia Ercoli; Chiara Pesenti; Eleonora Bonaparte; Elena Guerini-Rocco; Andrea Di Cristofori; Marco Locatelli; Alessandro Palleschi; Stefano Ferrero
Journal:  Med Oncol       Date:  2017-12-01       Impact factor: 3.064

5.  Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.

Authors:  Kunio Iura; Kenichi Kohashi; Nobuko Yasutake; Takeaki Ishii; Akira Maekawa; Hirofumi Bekki; Hiroshi Otsuka; Yuichi Yamada; Hidetaka Yamamoto; Yoshihiro Ohishi; Yoshihiro Matsumoto; Yukihide Iwamoto; Yoshinao Oda
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

6.  IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression.

Authors:  Sanjoy Samanta; Bryan Pursell; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

7.  Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.

Authors:  Magdalena Slosar; Poonam Vohra; Manju Prasad; Andrew Fischer; Robert Quinlan; Ashraf Khan
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

8.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.

Authors:  David F Schaeffer; Daniel R Owen; Howard J Lim; Andrew K Buczkowski; Stephen W Chung; Charles H Scudamore; David G Huntsman; Sylvia S W Ng; David A Owen
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

9.  Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa.

Authors:  Johanna D Strehl; Josef Hoegel; Ines Hornicek; Arndt Hartmann; Marc-Oliver Riener
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese cases.

Authors:  Xiangjie Sun; Ping Wei; Chen Shen; Yusi Yang; Yiqin Wang; Yuan Li; Xiang Du
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.